All lobbying filings

FORBES-TATE

Lobbying for GENENTECH · A biotechnology corporation

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 15, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Intellectual property and process patent related issues.

Medicare/Medicaid

Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act; Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.

Taxation/Internal Revenue Code

Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act; Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act; Issues related to the Medicaid Drug Rebate Program.

Manufacturing

Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act; Issues related to the Medicaid Drug Rebate Program.

Budget/Appropriations

Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act; Issues related to the Medicaid Drug Rebate Program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.